BLCO
Bausch + Lomb CorporationNYSEHealthcare$16.49-1.14%ClosedMarket Cap: $5.84B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.90
P/S
1.14
EV/EBITDA
18.84
DCF Value
$8.56
FCF Yield
-1.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
58.7%
Operating Margin
3.1%
Net Margin
-7.1%
ROE
-5.6%
ROA
-2.6%
ROIC
1.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.41B | 58.1% | $158.0M | $-58.0M | $-0.16 | — |
| FY 2025 | $5.10B | 58.7% | $159.0M | $-360.0M | $-1.02 | — |
| Q3 2025 | $1.28B | 60.2% | $95.0M | $-28.0M | $-0.08 | — |
| Q2 2025 | $1.28B | 58.9% | $-11.0M | $-62.0M | $-0.18 | — |
| Q1 2025 | $1.14B | 57.6% | $-83.0M | $-212.0M | $-0.60 | — |
| Q4 2024 | $1.28B | 60.9% | $87.0M | $-3.0M | $-0.01 | — |
| FY 2024 | $4.79B | 60.9% | $162.0M | $-317.0M | $-0.90 | — |
| Q3 2024 | $1.20B | 61.2% | $43.0M | $4.0M | $0.01 | — |
| Q2 2024 | $1.22B | 60.3% | $26.0M | $-151.0M | $-0.43 | — |
| Q1 2024 | $1.10B | 61.4% | $6.0M | $-167.0M | $-0.48 | — |
| Q4 2023 | $1.17B | 60.7% | $49.0M | $-54.0M | $-0.15 | — |
| FY 2023 | $4.15B | 60.4% | $130.0M | $-260.0M | $-0.74 | — |